NO20050720L - Krystallformer av olanzapin og fremgangsmate for deres fremstilling - Google Patents

Krystallformer av olanzapin og fremgangsmate for deres fremstilling

Info

Publication number
NO20050720L
NO20050720L NO20050720A NO20050720A NO20050720L NO 20050720 L NO20050720 L NO 20050720L NO 20050720 A NO20050720 A NO 20050720A NO 20050720 A NO20050720 A NO 20050720A NO 20050720 L NO20050720 L NO 20050720L
Authority
NO
Norway
Prior art keywords
olanzapine
preparation
crystal forms
preparing
forms
Prior art date
Application number
NO20050720A
Other languages
English (en)
Norwegian (no)
Inventor
Franc Vrecer
Berta Kotar Jordan
Marija Greman
Original Assignee
Krka Tovarna Zdravil Dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil Dd filed Critical Krka Tovarna Zdravil Dd
Publication of NO20050720L publication Critical patent/NO20050720L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20050720A 2002-07-15 2005-02-10 Krystallformer av olanzapin og fremgangsmate for deres fremstilling NO20050720L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200175A SI21270A (sl) 2002-07-15 2002-07-15 Kristalne oblike olanzapina in postopki za njihovo pripravo
PCT/SI2003/000024 WO2004006933A2 (en) 2002-07-15 2003-07-14 Crystal forms of olanzapine and processes for their preparation

Publications (1)

Publication Number Publication Date
NO20050720L true NO20050720L (no) 2005-02-10

Family

ID=30113490

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050720A NO20050720L (no) 2002-07-15 2005-02-10 Krystallformer av olanzapin og fremgangsmate for deres fremstilling

Country Status (12)

Country Link
US (1) US7745429B2 (pl)
EP (1) EP1551414B1 (pl)
AU (1) AU2003256242A1 (pl)
CA (1) CA2493370C (pl)
EA (1) EA008055B1 (pl)
HR (1) HRP20050039B1 (pl)
NO (1) NO20050720L (pl)
PL (1) PL217081B1 (pl)
RS (1) RS53474B (pl)
SI (2) SI21270A (pl)
UA (1) UA83633C2 (pl)
WO (1) WO2004006933A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
US7323459B2 (en) * 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
AR047461A1 (es) * 2004-01-27 2006-01-18 Synthon Bv Formacion, purificacion y uso de n-formilolanzapina
ATE504588T1 (de) 2004-01-27 2011-04-15 Synthon Bv Stabile salze von olanzapin
CA2557986A1 (en) * 2004-03-08 2005-09-15 Krka Tovarna Zdravil, D.D., Novo Mesto Isopropanol water solvate of olanzapine
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
GB0522473D0 (en) 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU629879A3 (ru) 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US5229382A (en) 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5776928A (en) * 1995-04-21 1998-07-07 Eli Lilly And Company Method for treating dyskinesias with olanzapine
US6506746B2 (en) * 1995-05-30 2003-01-14 Eli Lilly And Company Method for treating cognitive dysfunction
ZA978515B (en) 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
CZ299247B6 (cs) 1996-09-23 2008-05-28 Eli Lilly And Company Olanzapin dihydrát D
AU9583498A (en) * 1997-09-30 1999-04-23 Eli Lilly And Company Method for treating sexual dysfunction
CA2395774C (en) * 1999-12-28 2009-09-15 Cipla Limited New polymorphic forms of olanzapine
SK2502003A3 (en) 2000-08-31 2004-03-02 Reddys Lab Ltd Dr Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Also Published As

Publication number Publication date
PL217081B1 (pl) 2014-06-30
WO2004006933A3 (en) 2004-04-01
EA200500188A1 (ru) 2005-06-30
US7745429B2 (en) 2010-06-29
EP1551414B1 (en) 2013-11-27
CA2493370C (en) 2009-09-29
RS53474B (sr) 2014-12-31
WO2004006933A2 (en) 2004-01-22
UA83633C2 (ru) 2008-08-11
RS20050023A (sr) 2007-06-04
CA2493370A1 (en) 2004-01-22
HRP20050039A2 (en) 2005-08-31
AU2003256242A1 (en) 2004-02-02
US20060040920A1 (en) 2006-02-23
SI21270A (sl) 2004-02-29
PL373845A1 (pl) 2005-09-19
SI1551414T1 (sl) 2014-04-30
HRP20050039B1 (hr) 2014-10-10
EP1551414A2 (en) 2005-07-13
EA008055B1 (ru) 2007-02-27

Similar Documents

Publication Publication Date Title
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
NO20034289L (no) N-(2-aryletyl)benzylaminer som antagonister av 5-HT6- reseptoren
NO20044221L (no) Nye forbindelser
DK1888541T3 (da) Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
WO2005069784A3 (en) Public access point
NO20052591D0 (no) Pyridopyrolizin og pyridoindolizinderivater
ATE393764T1 (de) Polymorphe formen von valsartan
GEP20063894B (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
PL371127A1 (pl) Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
NO20050720L (no) Krystallformer av olanzapin og fremgangsmate for deres fremstilling
DK0981525T3 (da) (2-(2-Thienyl)-ethylamino)-(2-halophenyl)-acetonitriler som mellemprodukter og fremgangsmåde til deres fremstilling
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
WO2005060693A3 (en) 9-desoxoerythromycin compounds as prokinetic agents
NO20024321L (no) Fremgangsmate for fremstilling av krystallinsk form I av kabergolin
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
NO20071634L (no) Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner
DK1673354T3 (da) Arylindenopyridiner og arylindenopyrimidiner og deres anvendelse som adenosin-A2a-receptorantagonister
NO20053473D0 (no) Fremgangsmate for fremstilling av R,R (eller S,S) konfigurasjonen av glykopyrroniumstereoisomerer
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
NO20044473L (no) Ikke-steroidal progesteron reseptor modulatorer
DK1638948T3 (da) Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere